المؤلفون: Bair, Steven M, Strelec, Lauren E, Feldman, Tatyana A, Ahmed, Gulrayz, Armand, Philippe, Shah, Nirav N, Singavi, Arun N, Reddy, Nishitha, Khan, Nadia, Andreadis, Charalambos, Vu, Khoan, Huntington, Scott F, Giri, Smith, Ujjani, Chaitra, Howlett, Christina, Faheem, Malik, Youngman, Matthew R, Nasta, Sunita D, Landsburg, Daniel J, Schuster, Stephen J, Svoboda, Jakub

المصدر: The Oncologist. 24(7)

مصطلحات موضوعية: Biomedical and Clinical Sciences, Cardiovascular Medicine and Haematology, Clinical Sciences, Oncology and Carcinogenesis, Hematology, Rare Diseases, Clinical Research, Cancer, Lymphoma, Evaluation of treatments and therapeutic interventions, 6.1 Pharmaceuticals, Adolescent, Adrenal Cortex Hormones, Adult, Aged, Aged, 80 and over, Antineoplastic Agents, Immunological, Drug-Related Side Effects and Adverse Reactions, Female, Follow-Up Studies, Hodgkin Disease, Humans, Male, Middle Aged, Nivolumab, Prognosis, Programmed Cell Death 1 Receptor, Retrospective Studies, Survival Rate, Young Adult, Hodgkin lymphoma, Immunotherapy, PD-1 inhibitor, Real-world, Checkpoint inhibitor, PD‐1 inhibitor, Real‐world, Oncology & Carcinogenesis, Oncology and carcinogenesis

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/3q05t8vfTest

المؤلفون: Horwitz, Steven¹ horwitzs@mskcc.org, O'Connor, Owen A.², Pro, Barbara³, Illidge, Tim⁴, Fanale, Michelle^5,6, Advani, Ranjana⁷, Bartlett, Nancy L.⁸, Christensen, Jacob Haaber⁹, Morschhauser, Franck¹⁰, Domingo-Domenech, Eva¹¹, Rossi, Giuseppe¹², Won Seog Kim¹³, Feldman, Tatyana¹⁴, Lennard, Anne¹⁵, Belada, David¹⁶, Illés, Árpád¹⁷, Kensei Tobinai¹⁸, Kunihiro Tsukasaki¹⁹, Su-Peng Yeh²⁰, Shustov, Andrei²¹

المصدر: Lancet. 1/19/2019, Vol. 393 Issue 10168, p229-240. 12p.

مصطلحات موضوعية: *ANTINEOPLASTIC agents, *CLINICAL trials, *COMPARATIVE studies, *DOXORUBICIN, *IMMUNOGLOBULINS, *IMMUNOLOGICAL adjuvants, *RESEARCH methodology, *MEDICAL cooperation, *PREDNISONE, *PROGNOSIS, *RESEARCH, *RESEARCH funding, *VINCRISTINE, *EVALUATION research, *RANDOMIZED controlled trials, *BLIND experiment, *CYCLOPHOSPHAMIDE, *T-cell lymphoma

المؤلفون: Thomas E. Witzig, Pier Luigi Zinzani, Tatyana Feldman, Grzegorz S. Nowakowski, Lisa M. Rimsza, Jason R. Westin

المساهمون: Nowakowski, Grzegorz S, Feldman, Tatyana, Rimsza, Lisa M, Westin, Jason R, Witzig, Thomas E, Zinzani, Pier Luigi

المصدر: Blood Cancer Journal, Vol 9, Iss 6, Pp 1-10 (2019)
Blood Cancer Journal

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Concordance, Clinical Decision-Making, Review Article, lcsh:RC254-282, Phase II trials, Advance Care Planning, 03 medical and health sciences, diffuse large B-cell lymphoma, cell evaluation, 0302 clinical medicine, Recurrence, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Biomarkers, Tumor, medicine, Humans, Precision Medicine, Medical diagnosis, Radiation treatment planning, B-cell lymphoma, business.industry, Clinical study design, Disease Management, Cancer, Hematology, Prognosis, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Precision medicine, medicine.disease, Clinical trial, Treatment Outcome, 030220 oncology & carcinogenesis, Disease Susceptibility, Lymphoma, Large B-Cell, Diffuse, business, Diffuse large B-cell lymphoma, 030215 immunology

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::acf0491db0b5fd7685c79d5252e78d7aTest
http://hdl.handle.net/11585/738032Test